Pharma's Almanac TVPA TV
  • Follow the Completed Journey
  • Companies We've Met
  • AES Clean Technology
  • Altis Biosystems
  • Arranta Bio
  • Avara Pharmaceutical Services
  • Avid Bioservices
  • BioVectra
  • Centaur BPS
  • Dynamk Capital
  • ECRI
  • Evolve Biologics
  • Federal Equipment Company
  • Globyz
  • Inceptor Bio
  • IPS-Integrated Project Services
  • Olon
  • Pii
  • Polpharma Biologics
  • PPD
  • RoosterBio
  • SanaClis
  • Sanofi AIS
  • SGD Pharma
  • SPI Pharma
  • TriRx Pharmaceutical Services
  • Yourway
  • Follow the Completed Journey
  • Companies On The Road
  • Follow The Artist
  • ABS
  • aCGT Vector
  • Alconox Inc.
  • Andelyn Biosciences
  • Arranta Bio
  • Avid Bioservices
  • BDD
  • BIOVECTRA
  • DPS Group
  • Dynamk Capital
  • Environmental Systems Corporation
  • Federal Equipment Company
  • Genesis AEC
  • Globyz Biopharma Services
  • Grifols Partnership
  • IDT Biologika
  • Inceptor Bio
  • IPS-Integrated Project Services
  • Kineticos Life Sciences
  • MilliporeSigma
  • Montana BioScience Alliance
  • Olon
  • Rentschler Biopharma
  • SanaClis
  • Scorpion Biological Services
  • Secant Group
  • Tapemark
  • VITRONIC
Dashboard
Your Name
Your Email
  • Manage Account
  • Sign Out
Sign In
Register
    • Topics
        Products
        • ADC
        • API - Small Molecule
        • Biologics
        • Biopharmaceuticals
        • Biosimilars
        • Cell and Gene Therapy
        • DNA
        • Drug Product
        • Drug Substance
        • Equipment
        • Generics
        • Immunotherapy
        • Injectables
        • Monoclonal Antibody
        • Novel Therapeutics
        • Oral Solid Dosage
        • Orphan Drugs
        • Parenterals
        • Stem Cells
        • Vaccine
        Services
        • Big Data
        • Bioprocessing
        • Clinical Trials
        • Continuous Manufacturing
        • Diagnostics
        • Drug Delivery
        • Drug Development
        • Drug Discovery
        • Facility
        • Formulation
        • Innovation
        • Oncology
        • Patient Adherence
        • Patient Centric
        • Preclinical
        • Process Development
        • Quality
        • Regulatory
        • Research
        • Serialization
        Segment
        • Biomanufacturing
        • Biotechnology
        • CDMO
        • Consulting
        • CRO
        • Engineering
        • Equipment
        • Excipients
        • Healthcare
        • Intermediates
        • Logistics
        • Manufacturing
        • Packaging
        • Supply Chain
        Business
        • Agreement
        • Appointment
        • Business
        • Capacity Expansion
        • Collaboration
        • Growth
        • Investment
        • Licensing
        • M&A
        • Market Expansion
        • Market Intelligence
        • Market Prediction
        • New Facility
        • Strategic Partnership
    • Magazine
      • Archive
    • Reports
      • 2021 Cell & Gene Therapy Report
      • 2021 Monoclonal Antibody & Recombinant Protein Market Report
      • 2022 Sterile Drug Market Report
      • 2022 API Market Report
      • 2022 OSD Market Report
    • Community
    • Company A to Z
    • Follow the Journey
    • Companies On The Road
    • Follow The Artist
    • More+
      • Staffing
      • Media Kit

    Protein

    6 Articles Available

    Can't find what you're looking for? Try our advanced search.

    FDA Approval

    Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins
    PR-M08-18-NI-123

    Innovation

    Bruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five Minutes
    PR-M03-18-NI-051

    Cell-Line

    Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics
    PR-M03-18-NI-045

    Drug Development

    Celgene, Vividion Therapeutics Collaborate on Novel Protein Drugs
    PAO-M03-18-NI-005

    Oncology

    Inside Out: Targeting Proteins on Cancer Cells
    PTV-M06-17-BIO-013

    Innovation

    Merck Signs Global License Agreement for Potential Treatment for Alzheimer’s Disease
    PAO-M06-17-NI-001

    About Us
    That’s Nice Staffing
    More
    Media Kit Download Current Issue
    Your Account
    Manage Your Account Dashboard Sign Out
    Sign In Register
    Help
    Contact Us Support
    Nice Insight/That’s Nice

    89 Fifth Avenue
    Fifth Floor
    New York
    NY 10003-3020

    New York – San Diego – Chicago
    London – Frankfurt – Shanghai

    Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

    © PHARMA’S ALMANAC 2022 Terms and Conditions